January 5, 2017
BMS, Janssen to test cancer drug together
BMS and Janssen Biotech announced continuation of their work together through a new clinical research.
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
January 5, 2017
FDA focuses on false drugs promotions
The U.S. Food and Drug Administration (FDA) has said that it plans to take a better look on how drug-makers describe their products and to make them focus on better explaining what the drug exactly do, and how consumers and healthcare professionals (HCPs) can detect false promotions.
January 5, 2017
Ceylad kicks off THINK cancer trial in Belgium, blood taken from the first patient
Celyad has started on Thursday its Therapeutic Immunotherapy with NKR-2 (THINK) trial in Belgium with the first patient giving blood.
To remind, THINK trial is an open-label Phase Ib study to assess the safety and clinical activity of multiple administrations of autologous CAR-T NKR-2 cells in seven refractory cancers.
January 5, 2017
Valneva, Merck in new animal vaccines deal (U.S.&Canada)
Valneva has given Merck in United States and Canada rights to use its EB66 technology to research new veterinary vaccines.
January 5, 2017
Futura Medicals launches condom in Saudi Arabia, expects further distribution in MENA
Transdermal technology specialist Futura Medicalis has made an – at least to say – interesting step in Saudi Arabia, country…
January 5, 2017
OptiBiotix replaces Commercial Director
OptiBiotix Health is rearranging its directorial staff as it has changed its Commercial Director. Namely, Jim Laird will be substituted by Per Rehné to that directorial position.
January 5, 2017
Nicox provides clinical and regulatory update for NCX 4251 in blepharitis
Nicox has provided certain regulatory and clinical updates for NCX 4251, its novel ophthalmic suspension of fluticasone propionate nanocrystals being…
January 5, 2017
Neovacs and Professor Robert Kerbel together fight cancer
Neovacs and Professor Robert Kerbel and his team at the Sunnybrook Research Institute of Toronto, Canada are about to join…
January 4, 2017
Bayer nets FDA’s priority review for cancer drug in U.S.
Bayer has started off the new year with another approval from theU.S. Food and Drug Administration (FDA).
January 4, 2017
Sanofi’s type 2 diabetes drug available in U.S.
Sanofi’s Soliqua 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by prescription in U.S. pharmacies.